Network Modeling and Analysis in Health Informatics and Bioinformatics最新文献

The use of static graphs for modelling and analysis of biological and biomedical data plays a key role in biomedical research. However, many real-world scenarios present dynamic behaviours resulting in both node and edges modification as well as feature evolution. Consequently, ad-hoc models for capturing these evolutions along the time have been introduced, also referred to as dynamic, temporal, time-varying graphs. Here, we focus on temporal graphs, i.e., graphs whose evolution is represented by a sequence of time-ordered snapshots. Each snapshot represents a graph active in a particular timestamp. We survey temporal graph models and related algorithms, presenting fundamentals aspects and the recent advances. We formally define temporal graphs, focusing on the problem setting and we present their main applications in biology and medicine. We also present temporal graph embedding and the application to recent problems such as epidemic modelling. Finally, we further state some promising research directions in the area. Main results of this study include a systematic review of fundamental temporal network problems and their algorithmic solutions considered in the literature, in particular those having application in computational biology and medicine. We also include the main software developed in this context.

X-ray is a useful imaging modality widely utilized for diagnosing COVID-19 virus that infected a high number of people all around the world. The manual examination of these X-ray images may cause problems especially when there is lack of medical staff. Usage of deep learning models is known to be helpful for automated diagnosis of COVID-19 from the X-ray images. However, the widely used convolutional neural network architectures typically have many layers causing them to be computationally expensive. To address these problems, this study aims to design a lightweight differential diagnosis model based on convolutional neural networks. The proposed model is designed to classify the X-ray images belonging to one of the four classes that are Healthy, COVID-19, viral pneumonia, and bacterial pneumonia. To evaluate the model performance, accuracy, precision, recall, and F1-Score were calculated. The performance of the proposed model was compared with those obtained by applying transfer learning to the widely used convolutional neural network models. The results showed that the proposed model with low number of computational layers outperforms the pre-trained benchmark models, achieving an accuracy value of 89.89% while the best pre-trained model (Efficient-Net B2) achieved accuracy of 85.7%. In conclusion, the proposed lightweight model achieved the best overall result in classifying lung diseases allowing it to be used on devices with limited computational power. On the other hand, all the models showed a poor precision on viral pneumonia class and confusion in distinguishing it from bacterial pneumonia class, thus a decrease in the overall accuracy.

AI-driven approaches are widely used in drug discovery, where candidate molecules are generated and tested on a target protein for binding affinity prediction. However, generating new compounds with desirable molecular properties such as Quantitative Estimate of Drug-likeness (QED) and Dopamine Receptor D2 activity (DRD2) while adhering to distinct chemical laws is challenging. To address these challenges, we proposed a graph-based deep learning framework to generate potential therapeutic drugs targeting the SARS-CoV-2 protein. Our proposed framework consists of two modules: a novel reinforcement learning (RL)-based graph generative module with knowledge graph (KG) and a graph early fusion approach (GEFA) for binding affinity prediction. The first module uses a gated graph neural network (GGNN) model under the RL environment for generating novel molecular compounds with desired properties and a custom-made KG for molecule screening. The second module uses GEFA to predict binding affinity scores between the generated compounds and target proteins. Experiments show how fine-tuning the GGNN model under the RL environment enhances the molecules with desired properties to generate $100\%$ valid and $100\%$ unique compounds using different scoring functions. Additionally, KG-based screening reduces the search space of generated candidate molecules by $96.64\%$ while retaining $95.38\%$ of promising binding molecules against SARS-CoV-2 protein, i.e., 3C-like protease (3CLpro). We achieved a binding affinity score of 8.185 from the top rank of generated compound. In addition, we compared top-ranked generated compounds to Indinavir on different parameters, including drug-likeness and medicinal chemistry, for qualitative analysis from a drug development perspective.

Supplementary information: The online version contains supplementary material available at 10.1007/s13721-023-00409-2.

Health care is ever more important with the aging population and with the increased awareness of the importance of the medical systems due to the corona crisis that showed the capacity of the health care infrastructure, especially in terms of numbers of health care personnel such as doctors, was not sufficient. Assuming that the number of doctors per patient is one of the determinants of patient satisfaction, optimal investments in new doctors, specialist doctors and foreign doctors are analyzed. Optimal Control Theory is employed to determine the optimal investment strategy for new doctors (new graduates), specialists and foreign doctors to maximize the net (of costs) patient satisfaction over a fixed time horizon. It is found that a nation with an insufficient number of total doctors and specialist doctors at the beginning of the planning horizon should increase the investment in new doctors as a quadratic function of time, increase the local specialist doctors linearly, while employing foreign doctors as to equate their cost to the marginal satisfaction of patients.